Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins
about
Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cellsbeta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosisRole of advanced glycation end products in cellular signalingAdvanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complexAdvanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36.Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasisControlling the receptor for advanced glycation end-products to conquer diabetic vascular complicationsCo-expression of BirA with biotin bait achieves in vivo biotinylation of overexpressed stable N-glycosylated sRAGE in transgenic silkworms.The AGE-receptor in the pathogenesis of diabetic complications.Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF.Regulation of RAGE for attenuating progression of diabetic vascular complications.Carbonyl stress and diabetic complications.Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.Role of glycation in aging.Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteinsAdvanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.Localization of the ezrin binding epitope for glycated proteins.Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEsReceptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factorMolecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.What is the role of the receptor for advanced glycation end products-ligand axis in liver injury?Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diaAdvanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling.Mechanisms of distal axonal degeneration in peripheral neuropathies.Diabetes mellitus in patients with cirrhosis: clinical implications and management.Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amylRegulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.The use of optical sensors to understand cellular interactions with renal cells.Advanced glycation end-products and atherosclerosis.Atherogenesis and advanced glycation: promotion, progression, and prevention.Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease.The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications.Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes.
P2860
Q24530074-F34199BC-415E-4E89-AD24-A940F0116296Q24597379-2206EBCC-1B6E-479A-A9EE-240D781BB8CEQ27003423-7C2A934D-4F2B-4977-BCE6-8D2B859931DBQ28366662-C2FBEDC7-6FF9-4ED9-88B3-2A721FF90E53Q28577438-AF586793-B2DA-4F98-B76C-C15C823D7DC8Q30518002-9F9EF479-3802-42FE-B425-ADF25262ED73Q32085442-8CEE1692-A086-4785-BFC8-5C3CFA9804DBQ33609776-1EE3BD59-A9C9-42BD-987D-85F64EE0531DQ33671771-F86567FF-A240-4005-B410-F700B05069C7Q34470639-243DA709-55B4-4272-8217-FB5DBEC1BAB1Q34728855-2511E32A-D7AD-44DD-8F82-67C63A75C004Q34733351-CE16CD12-3988-4DBB-B640-BA26B6DA234FQ35494903-8FA0D3F8-BBEE-4D89-827B-B77730080E4EQ35576070-8CA1E22F-9067-4A11-836E-7EB5F399BED0Q35605061-849C535A-AF45-4DD3-AF9A-BA9716D22F36Q35656681-C21C5E64-07D3-4E8C-97DA-E227CA43EED4Q35661794-A61D387B-89A9-4D64-A520-0BF3AFB73011Q35748423-43D75ABD-F31A-4F77-8DCA-5005786AA3C5Q35764706-FF80C007-319B-4790-948A-0AAFB66F3ADAQ35798371-BBA0BD15-875C-4E1E-9E63-E9C28F7D9CE2Q36203989-DE929B9C-E096-4BB3-ADC0-83B89DD18D4AQ36437790-35F1AC09-F362-4172-A518-75D21E5D3B6AQ36925657-F548B70E-DD9A-4DF4-80CC-0AFAFD5C8915Q37308593-75556D40-3FD3-4524-8155-3775DC3C6BF1Q37348615-7B4638A1-EA7C-4336-B293-5EECBD5FC2ECQ37362121-2CC44D6C-7E24-4374-91B8-80E5805595A0Q37857797-9C0D2D14-D6DE-4735-93A6-834D110C3662Q38292287-27332296-C162-4EB6-B09D-5F0ED260C908Q38313889-8D9769A9-388D-4D9A-A360-28D1C11D32B2Q38330759-468CD721-347C-4CEC-BF4D-5DE39777096FQ38773241-9AE7479E-19D8-46ED-8237-5BFEBDFD692FQ39759463-F2A88492-EB12-4846-9F11-DAC28D565474Q39770000-6FC52B15-73AD-4032-9007-CA155D2A8AEFQ40304611-5A4F66CE-FAFA-4543-94D6-145B44308611Q40940329-FBB7C2D8-C27A-4A72-80B0-5CEDD4E85D1EQ41250355-FE19B7AD-DE03-4D61-9C24-F53655A59273Q41500579-93DBD815-B8BB-4708-84D3-A2C08FB57AB4Q42790513-35DDAFC2-67A0-402B-A480-F05E22D6DE71Q44432075-E3895C64-BE9C-4E6F-AB34-E1C852D0FC0AQ48900914-396FD4A0-9454-4BD3-8610-516B90BD6201
P2860
Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins
description
1991 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1991
@ast
im September 1991 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1991/09/01)
@sk
vědecký článek publikovaný v roce 1991
@cs
wetenschappelijk artikel (gepubliceerd op 1991/09/01)
@nl
наукова стаття, опублікована у вересні 1991
@uk
مقالة علمية (نشرت في سبتمبر 1991)
@ar
name
Two novel rat liver membrane p ...... for glucose-modified proteins
@ast
Two novel rat liver membrane p ...... for glucose-modified proteins
@en
Two novel rat liver membrane p ...... for glucose-modified proteins
@nl
type
label
Two novel rat liver membrane p ...... for glucose-modified proteins
@ast
Two novel rat liver membrane p ...... for glucose-modified proteins
@en
Two novel rat liver membrane p ...... for glucose-modified proteins
@nl
prefLabel
Two novel rat liver membrane p ...... for glucose-modified proteins
@ast
Two novel rat liver membrane p ...... for glucose-modified proteins
@en
Two novel rat liver membrane p ...... for glucose-modified proteins
@nl
P2093
P2860
P921
P356
P1476
Two novel rat liver membrane p ...... for glucose-modified proteins
@en
P2093
H. Vlassara
M. Suthanthiran
P. Sehajpal
S. Brunelle
P2860
P304
P356
10.1084/JEM.174.3.515
P407
P577
1991-09-01T00:00:00Z